Note: Ingredients listed on restricted chemical lists
EC/CAS
215-481-4/1327-53-3
Name of the chemical
Diarsenic trioxide
Concentration
N/A
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
<1
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
<1
General Information
Version
0
Revision date
2018-01-11
Product name
Arsenic Trioxide 1 mg/mL Solution for Infusion
Manufacturer Name
NerPharMa srl
Emergency telephone
+39 331 581111
Icons in SDS
Company Information
company name
NerPharMa srl
e-mail address of the competent person responsible for the Safety Data Sheet
MDSD@nmsgroup.it
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H350
Hazard statements
Code
Statements
H350
May cause cancer
Section 2
SECTION 2: Hazards identification
Signal word
DANGER! GHS Class: Carcinogenicity, Category 1.
Hazard statements
H350 May cause cancer
Precautionary statements
P201 Obtain special instruction before use P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 IF exposed or concerned: Get medical advice/attention. P405 Store locked up P501 Dispense contents/container in accordance with local/regional/ national/ international regulations Hazards not otherwise classified that have been identified during the classification process: Emergency Overview: This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye: May cause severe eye damage. Skin: May cause severe skin burns. Inhalation: May cause irritation of respiratory tract. Ingestion: If ingested, substance is considered toxic.